AIM AIM ImmunoTech, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

AIM ImmunoTech (AIM) kompaniyasining rasmiy ramzlari

Noyob immunomodulyator Ampligen monetizatsiyasi AIM ImmunoTech uchun barqaror daromadlar poydevorini yaratadi. Kompaniyaning P/BV koeffitsiyenti tarixi aktivlar qiymati dinamikasini aks ettiradi, bunda ushbu ko'rsatkich 0.60 ga tengdir. Biznes barqarorligi diversifikatsiyalashgan reagent yetkazib berish kanallari hamda saxovatli opsion dasturlari va kuchli R&D resursi orqali jalb qilingan ekspertlar tarkibidagi akademik xodimlar tomonidan qo'llab-quvvatlanadi.

AIM ImmunoTech (AIM) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

AIM (AIM ImmunoTech, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi AIM ImmunoTech Inc.|AIM - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi AIM ImmunoTech|AIM - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati AIM ImmunoTech|AIM - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati aimimmuno.com|AIM - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati AIM ImmunoTech|AIM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati AIM ImmunoTech|AIM - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati AIM ImmunoTech
Kompaniyaning asosiy tahlili:AIM (AIM ImmunoTech Inc.)
AIM ImmunoTech, Inc. tayyor mahsulotlari

AIM ImmunoTech dori vositalarining kengayish salohiyati yagona muvaffaqiyatli formulaning tadqiqot va ishlanmalar (R&D) xarajatlarining rentabelligini ko'paytirishiga imkon beradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati grafigini tahlil qilish ushbu istiqbollarga tegishli bozor kutuvlarini baholash imkonini beradi. mvsbcap_co ko'rsatkichi kompaniyaning sof aktivlariga nisbatan qiymat premiumini o'lchaydi. Yuqori koeffitsient investorlarning kelajakdagi superfoydaga bo'lgan ishonchini aks ettiradi, bu esa potensial korreksiyadan oldin aktivning haddan tashqari sotib olinganlik darajasini aniqlashga yordam beradi.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati argenx SE (ARGX)|biontech.de (BNTX) - Sof aktivlarga nisbatan bozor kapitallashuvi|ABVX - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ADMA Biologics Inc|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|Bozor kapitallashuvining balans qiymatiga nisbati IMVT (Immunovant Therapeutics)|Bozor qiymatining balans qiymatiga nisbati Kiniksa Pharmaceuticals|grifols.com - Balans qiymatiga nisbatan bozor qiymati|ADPT: Bozor qiymatining balans qiymatiga nisbati|CLDX - Kapitallashuvning sof aktivlarga nisbati|AUPH: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BioCryst Corp|VERA - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati dianthustx.com|PHVS (Pharvaris) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ABCL (AbCellera Biologics)|Tourmaline Corp - Bozor qiymatining balans qiymatiga nisbati|Precigen Corp - Kapitallashuvning sof aktivlarga nisbati|PHAR: Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Immunome Corp (IMNM)|Kapitallashuvning balans qiymatiga nisbati Gossamer Bio Corp.|KalVista Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti septerna.com (SEPN)|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|ANAB: Balans qiymatiga nisbatan bozor kapitallashuvi|ATXS (Astria Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati engene.com|RAPT - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Aerovate|ACRS (Aclaris) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi KYTX (Kyverna Therapeutics, Inc)|Tiziana Life Sciences - Bozor qiymatining balans qiymatiga nisbati|cabalettabio.com - Kapitallashuvning sof aktivlarga nisbati|VTYX: Bozor qiymatining balans qiymatiga nisbati|Theratechnologies, Inc. (THTX) - Kapitallashuvning sof aktivlarga nisbati|AVTX: Kapitallashuvning sof aktivlarga nisbati|ELDN (Eledon Pharmaceuticals, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Agenus (AGEN)|Kapitallashuvning balans qiymatiga nisbati CLYM|Zura Bio - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti aTyr Pharma Inc ATYR|Kapitallashuvning sof aktivlarga nisbati Adagene Inc. (ADAG)|Bozor kapitallashuvining balans qiymatiga multiplikatori ImageneBio IMA|STTK (Shattuck Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|EQ - Bozor qiymatining balans qiymatiga koeffitsiyenti|CNTB (connectbiopharm.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Immunic (IMUX) - Kapitallashuvning sof aktivlarga nisbati|ATRA - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati InflaRx GmbH|Bozor kapitallashuvining balans qiymatiga nisbati XFOR|Bozor kapitallashuvining balans qiymatiga nisbati adicetbio.com (ACET)|Bozor kapitallashuvining balans qiymatiga nisbati CELU|INmune Bio Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|BRNS: Bozor qiymatining balans qiymatiga nisbati|KZR: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Sof aktivlarga nisbatan bozor kapitallashuvi|ENLV - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Q32 Bio Corp|Bozor kapitallashuvining balans qiymatiga nisbati GOVX|Bozor kapitallashuvining balans qiymatiga nisbati EDSA (Edesa Biotech Corp)|Bozor qiymatining balans qiymatiga nisbati iBio, Inc.|Carisma Therapeutics Inc - Balans qiymatiga nisbatan bozor qiymati|XTLB: Bozor qiymatining balans qiymatiga nisbati|BOLT - Kapitallashuvning sof aktivlarga nisbati|HCWB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Aptevo Therapeutics Inc.|ADTX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati gribio.com|XRTX (XORTX Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HIND (Vyome Holdings Inc.)|Revelation Bio - Bozor qiymatining balans qiymatiga nisbati|Indaptus Corp - Kapitallashuvning sof aktivlarga nisbati|SCNI: Bozor qiymatining balans qiymatiga nisbati|CalciMedica, Inc. (CALI) - Kapitallashuvning sof aktivlarga nisbati|AFMD: Kapitallashuvning sof aktivlarga nisbati|ALLK (Allakos) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc. (HOOK)|Kapitallashuvning balans qiymatiga nisbati IGM Bio|iTeos Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD